Ascelia’s pivotal study seems to be on track, and the company repeats the goal to reach the full enr...
Marimekko’s Q2 result was strong and broadly in line with expectations.
Q2 EBITA +8% vs ABGSCe driven by 10% sales beat Guidance upgrade as expected but highlights slowdown...
Redeye saw sales a bit lower than our expectations for the quarter.
Sales 37% below ABGSC, down 33% y-o-y Lower guidance somewhat outweighed by large ‘23 order Cons ’22...
Redeye's first comments on the Q2 report this morning.
Net sales SEK 57m, adj. EBITDA SEK -4.3m Q2 numbers imply 15-20% adj.
Redeye will likely make minor forecast adjustments following Binero’s Q2’22 report, where the revenu...
Redeye comments on Mestro’s Q2'22 report, which showed a CARR above our estimates while the margins ...
Redeye notes that Starbreeze Q2 report was stronger than expected.
Railcare posted solid numbers for the second quarter with a significant improvement Y/Y.
Redeye saw a Q2 report showing strong growth and a record high gross margin at 70%.
Operating losses in line with ABGSC est. Sales growth of 110% y-o-y to SEK 12.
Redeye updates its estimates following Sleep Cycle’s Q2’22 report.
Redeye updates its estimates and valuation for Adverty, following the Q2’22 report.
As the Q2 report and the trading update for Q3 did not contain any surprises, we leave our 2022-24 e...
Continued series production ramp-up ’22e-’24e adj. EBIT up 5-3% on lower opex Fair value SEK 110-200...
Strong core business only offset by trading income Hunt for new corporate customers off to good star...
On August 17, 2022, Trophy Games Development A/S (“Trophy Games” or the “Company”) released their H1...
Bolaget minskar både omsättning och rörelseresultat under kvartalet men rapporten bjuder på några lj...
